Lariba, Charen .

HRN: 28-63-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/11/2026
04/11/2026
IV
1 Gram
Ptor
Cs
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: